A glycolysis inhibitor, 3-BP can inhibit cancer cell proliferation through energy metabolism interruption (6), primarily through inhibition of the glycolytic enzymes and those related with mitochondrial function, including hexokinase II (HK II) (7), pyruvate dehydrogenase (PDH) (6), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), lactate dehydrogenase (LDH), and by altering adenosine triphosphate (ATP) levels (8). Here, GAPDH is linked to cancer.